Identification of a novel factor XI gene mutational event in a Dutch Caucasian family with inherited factor XI deficiency

René Mulder; Sophie Wiewel-Verschueren; Karina Meijer; André B. Mulder

doi:10.1160/TH12-12-0933

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2013; 109(06): 1183-1185
DOI: 10.1160/TH12-12-0933

Letters to the Editor

Schattauer GmbH

Identification of a novel factor XI gene mutational event in a Dutch Caucasian family with inherited factor XI deficiency

René Mulder

¹Department of Laboratory Medicine, University of Groningen, University Medical Centre Groningen, the Netherlands

²Division of Haemostasis and Thrombosis, Department of Haematology, University of Groningen, University Medical Centre Groningen, the Netherlands

,

Sophie Wiewel-Verschueren

²Division of Haemostasis and Thrombosis, Department of Haematology, University of Groningen, University Medical Centre Groningen, the Netherlands

,

Karina Meijer

²Division of Haemostasis and Thrombosis, Department of Haematology, University of Groningen, University Medical Centre Groningen, the Netherlands

,

André B. Mulder

¹Department of Laboratory Medicine, University of Groningen, University Medical Centre Groningen, the Netherlands

› Author Affiliations

Abstract

Full Text

References

References
1 Kato A, Asakai R, Davie EW. et al. Factor XI gene (F11) is located on the distal end of the long arm of human chromosome 4. Cytogenet Cell Genet 1989; 52: 77-78.
2 Seligsohn U. Factor XI deficiency. Thromb Haemost 1993; 70: 68-71.
3 Bolton-Maggs PH, Young Wan-Yin B, McCraw AH. et al. Inheritance and bleeding in factor XI deficiency. Br J Haematol 1988; 69: 521-528.
4 Leiba H, Ramot B, Many A. Heredity and coagulation studies in ten families with Factor XI (plasma thromboplastin antecedent) deficiency. Br J Haematol 1965; 11: 654-665.
5 Asakai R, Davie EW, Chung DW. Organization of the gene for human factor XI. Biochemistry 1987; 26: 7221-7228.
6 Tosetto A, Castaman G, Rodeghiero F. Assessing bleeding in von Willebrand disease with bleeding score. Blood Rev 2007; 21: 89-97.
7 Tosetto A, Castaman G, Plug I. et al. Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation. J Thromb Haemost 2011; 09: 1143-1148.
8 Tosetto A, Rodeghiero F, Castaman G. et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multi-center European study (MCMDM-1 VWD). J Thromb Haemost 2006; 04: 766-773.
9 Zucker M, Rosenberg N, Peretz H. et al. Point mutations regarded as missense mutations cause splicing defects in the factor XI gene. J Thromb Haemost 2011; 09: 1977-1984.
10 Blencowe BJ. Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. Trends Biochem Sci 2000; 25: 106-110.
11 Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 2002; 03: 285-298.
12 Kravtsov DV, Wu W, Meijers JC. et al. Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain. Blood 2004; 104: 128-134.